相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
Kirk M. Habegger et al.
DIABETES (2013)
A Critical Analysis of the Clinical Use of Incretin-Based Therapies
Peter C. Butler et al.
DIABETES CARE (2013)
Effects of the dual PPAR-α/γ agonist aleglitazar on glycaemic control and organ protection in the Zucker diabetic fatty rat
A. Benardeau et al.
DIABETES OBESITY & METABOLISM (2013)
Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?
M. A. Nauck et al.
DIABETOLOGIA (2013)
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Jun Wu et al.
CELL (2012)
Recent advances in incretin-based therapies
David Russell-Jones et al.
CLINICAL ENDOCRINOLOGY (2012)
Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model
Belinda Gier et al.
DIABETES (2012)
An Update in Incretin-Based Therapy: A Focus on Glucagon-Like Peptide-1 Receptor Agonists
Krystal L. Edwards et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice
Emilie Faivre et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21
Timo D. Mueller et al.
JOURNAL OF PEPTIDE SCIENCE (2012)
Targeted estrogen delivery reverses the metabolic syndrome
Brian Finan et al.
NATURE MEDICINE (2012)
GIP-Overexpressing Mice Demonstrate Reduced Diet-Induced Obesity and Steatosis, and Improved Glucose Homeostasis
Su-Jin Kim et al.
PLOS ONE (2012)
Lateral Allosterism in the Glucagon Receptor Family: Glucagon-Like Peptide 1 Induces G-Protein-Coupled Receptor Heteromer Formation
Dominik Schelshorn et al.
MOLECULAR PHARMACOLOGY (2012)
GIP Does Not Potentiate the Antidiabetic Effects of GLP-1 in Hyperglycemic Patients With Type 2 Diabetes
Nikolaos Mentis et al.
DIABETES (2011)
Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo
S. Uhles et al.
DIABETES OBESITY & METABOLISM (2011)
Charge inversion at position 68 of the glucagon and glucagon-like peptide-1 receptors supports selectivity in hormone action
Jonathan W. Day et al.
JOURNAL OF PEPTIDE SCIENCE (2011)
GLP-1 and energy balance: an integrated model of short-term and long-term control
Jason G. Barrera et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Glucose Intolerance and Reduced Proliferation of Pancreatic β-Cells in Transgenic Pigs With Impaired Glucose-Dependent Insulinotropic Polypeptide Function
Simone Renner et al.
DIABETES (2010)
GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene
Su-Jin Kim et al.
JOURNAL OF LIPID RESEARCH (2010)
A GIP Receptor Agonist Exhibits β-Cell Anti-Apoptotic Actions in Rat Models of Diabetes Resulting in Improved β-Cell Function and Glycemic Control
Scott B. Widenmaier et al.
PLOS ONE (2010)
GIP: No Longer the Neglected Incretin Twin?
Rohit N. Kulkarni
SCIENCE TRANSLATIONAL MEDICINE (2010)
Exogenous Glucose-Dependent Insulinotropic Polypeptide Worsens Postprandial Hyperglycemia in Type 2 Diabetes
Chee W. Chia et al.
DIABETES (2009)
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Arne Astrup et al.
LANCET (2009)
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Jonathan W. Day et al.
NATURE CHEMICAL BIOLOGY (2009)
Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet
Matthew C. Althage et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet
Paula L. McClean et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes
Su-Jin Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis
Renee E. Amori et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes - A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade
Su-Jin Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
Tanya Hansotia et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively
NM Neary et al.
ENDOCRINOLOGY (2005)
Peripheral exendin-4 and peptide YY3-36 synergistically reduce food intake through different mechanisms in mice
T Talsania et al.
ENDOCRINOLOGY (2005)
Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors
T Hansotia et al.
DIABETES (2004)
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide - Regardless of etiology and phenotype
T Vilsboll et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice:: evidence that GIP is the major physiological incretin
VA Gault et al.
DIABETOLOGIA (2003)
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
K Miyawaki et al.
NATURE MEDICINE (2002)
Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide
VA Gault et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
分享论文
